You are here: Industry Insights > Amgen

News List

Amgen, Merck, Roche get in on Syapse’s $30M round fiercebiotech
November 16, 2017
Syapse picked up $30 million in series D financing, funds it will use to bring its oncology precision medicine software to more healthcare providers.
Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks biospace
November 16, 2017
Repatha, Amgen's PSCK9 inhibitor, continues to impress as a treatment for patients with peripheral artery disease (PAD) and a history of heart attacks
Amgen, Allergan Receive Positive CHMP for ABP 215 americanpharmaceuticacreview
November 13, 2017
Amgen and Allergan are collaborating on the development and commercialization of four oncology biosimilars. Amgen has a total of 10 biosimilars in its portfolio, one of which has been approved by the EC.
Banner Alzheimer's Institute, Novartis, and Amgen Expand Collaboration in Pioneering Alzheimer's Pre biospectrumasia
November 09, 2017
The API Generation Program is the first to incorporate both genetic testing and counselling in addition to amyloid disclosure education into the study screening process.
Amgen targets West Coast R&D jobs in latest round of cuts fiercebiotech
November 08, 2017
Amgen is laying off 200 people across its R&D organization. The latest victims of the big biotech’s ongoing pursuit of efficiency gains mainly work at its facilities in California.
Amgen and Science Centre Singapore launch the Amgen Biotech Experience (ABE) pharmaasia
November 08, 2017
The long-established Amgen innovative science education programme gives local secondary students real-world hands-on biotechnology lab experience.
Novartis, Amgen, BAI start new Alzheimer’s prevention Trial worldpharmanews
November 06, 2017
Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Initiative (API) Generation Study 2
Novartis, Amgen and Banner aim for Alzheimer’s prevention with new BACE trials fiercebiotech
November 03, 2017
We’ve seen it time and time again over the past 15 years from a particularly cruel disease that robs people of their memories and eventually kills them.
Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m pharmafile
November 01, 2017
Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would sell its 50% share in the partnership for $780 million.
Cancer Vanguard, Amgen develop commissioning toolkit pharmatimes
October 25, 2017
The Cancer Vanguard and Amgen have developed a simulation modelling tool to show health commissioners and trusts the financial benefits and challenges of delivering breast cancer medicines in a variety of community settings.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page